Mentice Past Earnings Performance
Past criteria checks 0/6
Mentice's earnings have been declining at an average annual rate of -2.9%, while the Healthcare Services industry saw earnings growing at 6.8% annually. Revenues have been growing at an average rate of 15.8% per year.
Key information
-2.9%
Earnings growth rate
0.3%
EPS growth rate
Healthcare Services Industry Growth | 7.9% |
Revenue growth rate | 15.8% |
Return on equity | -16.8% |
Net Margin | -8.4% |
Next Earnings Update | 13 Feb 2025 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Mentice makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
30 Sep 24 | 276 | -23 | 237 | 0 |
30 Jun 24 | 282 | -10 | 230 | 0 |
31 Mar 24 | 256 | -26 | 223 | 0 |
31 Dec 23 | 275 | -3 | 211 | 0 |
30 Sep 23 | 273 | 2 | 201 | 0 |
30 Jun 23 | 261 | -6 | 199 | 0 |
31 Mar 23 | 230 | -25 | 195 | 0 |
31 Dec 22 | 219 | -31 | 192 | 0 |
30 Sep 22 | 215 | -37 | 190 | 0 |
30 Jun 22 | 205 | -36 | 177 | 0 |
31 Mar 22 | 207 | -24 | 163 | 0 |
31 Dec 21 | 185 | -29 | 153 | 0 |
30 Sep 21 | 165 | -22 | 141 | 0 |
30 Jun 21 | 158 | -15 | 132 | 0 |
31 Mar 21 | 136 | -21 | 124 | 0 |
31 Dec 20 | 138 | -13 | 122 | 0 |
30 Sep 20 | 152 | -9 | 126 | 0 |
30 Jun 20 | 148 | -17 | 135 | 0 |
31 Mar 20 | 156 | -17 | 143 | 0 |
31 Dec 19 | 149 | -21 | 143 | 0 |
30 Sep 19 | 154 | -1 | 135 | 0 |
30 Jun 19 | 161 | 8 | 128 | 0 |
31 Mar 19 | 156 | 14 | 122 | 0 |
31 Dec 18 | 157 | 20 | 116 | 0 |
31 Dec 17 | 109 | 6 | 83 | 0 |
Quality Earnings: MN2 is currently unprofitable.
Growing Profit Margin: MN2 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: MN2 is unprofitable, and losses have increased over the past 5 years at a rate of 2.9% per year.
Accelerating Growth: Unable to compare MN2's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: MN2 is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare Services industry (3.6%).
Return on Equity
High ROE: MN2 has a negative Return on Equity (-16.79%), as it is currently unprofitable.